Xavier Quantin

8PUBLICATIONS
31CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsChemotherapyRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 28, 2026
The Place of Therapeutic Apheresis in Severe Immune-Related Adverse Events: A Scoping Review of Literature.

|Feb 13, 2026
Neoadjuvant Pembrolizumab Associated with Chemotherapy in Early Triple-Negative Breast Cancer Patients: Real-World Data from a French Single-Center Experience.

Ichrak Ben Abdallah, Severine Guiu, Xavier Quantin

|Nov 09, 2024
Optimizing Treatment Strategies for Egfr-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights.

Quentin Dominique Thomas, Nicolas Girard, Lise Bosquet

|Mar 29, 2024
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.

Joel Neal, Nick Pavlakis, Sang-We Kim

|Mar 13, 2024
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study.

Quentin Dominique Thomas, Mohamed Chaabouni, Anas Al Herk

|Mar 29, 2023
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.

Quentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi

Pageof 2

Frequent Collaborators

3 joint publications

Quentin Dominique Thomas

2 joint publications

Christos Chouaid

2 joint publications

William Jacot

1 joint publications

C Vuillet